Literature DB >> 16327120

Comparison of various microbiological tests including polymerase chain reaction for the diagnosis of osteoarticular tuberculosis.

S S Negi1, S Gupta, S Khare, S Lal.   

Abstract

PURPOSE: To evaluate the utility of the polymerase chain reaction (PCR) test for diagnosing osteoarticular tuberculosis (TB).
METHODS: Clinical samples (synovial tissue and synovial fluid) obtained from 23 cases of suspected osteoarticular tuberculosis were subjected to Ziehl Neelsen (ZN) smear examination, radiometric BACTEC culture and PCR test for tuberculosis by amplifying 65 kDa antigen coding region of Mycobacterium tuberculosis (M.tb) genome.
RESULTS: PCR test was found to be much sensitive than the ZN smear examination and BACTEC culture (p<0.05) in the diagnosis of osteoarticular TB. In synovial fluid samples, PCR was positive in 73.9%, ZN smear examination in 17.39% and BACTEC culture in 39.13% of cases. The positivities were relatively lower with synovial tissue samples, the corresponding figures being 60.8, 8.6 and 26.08% respectively. Moreover, on combining the results of synovial fluid and tissues, the corresponding figures further increased to 78.2, 21.7 and 43.3% respectively. Further, sensitivity and specificity for PCR employing BACTEC culture as the "gold standard" was 100% respectively. Using BACTEC culture, the earliest positivity was seen in three days using synovial tissue specimen and 13 days with synovial fluid, the average detection times being 23.2 days and 32.6 days respectively. On the other hand, PCR test gave a positive result within 24 hours.
CONCLUSIONS: PCR test was shown to be much more sensitive than ZN smear examination and BACTEC culture test for diagnosing osteoarticular tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16327120

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  8 in total

1.  The role of polymerase chain reaction in the management of osteoarticular tuberculosis.

Authors:  Vivek Pandey; Kiran Chawla; Kiran Acharya; Sripathi Rao; Sugandhi Rao
Journal:  Int Orthop       Date:  2007-11-24       Impact factor: 3.075

2.  Appearances are Deceptive: Staphylococcus Superinfection of Clavicular Tuberculous Osteomyelitis.

Authors:  Narendranath Epperla; Siddhartha Kattamanchi; Thomas R Fritsche
Journal:  Clin Med Res       Date:  2014-12-08

3.  Use of amplified Mycobacterium tuberculosis direct test (Gen-probe Inc., San Diego, CA, USA) in the diagnosis of tubercular synovitis and early arthritis of knee joint.

Authors:  Vinay Kumar Aggarwal; Deepthi Nair; Geetika Khanna; Jitender Verma; Vinod Kumar Sharma; Sumit Batra
Journal:  Indian J Orthop       Date:  2012-09       Impact factor: 1.251

4.  Evaluation of FLASH - PCR forrapid detection of Mycobacterium tuberculosis from clinical specimens.

Authors:  Abbas Ali Imani Fooladi; Yousef Tarvedi Zadeh; Rezvan Mehrab; Raheleh Halabian; Taghi Azizi
Journal:  Iran J Microbiol       Date:  2013-12

5.  The efficacy of diagnostic battery in Pott's disease: A prospective study.

Authors:  Manoj Kumar; Raj Kumar; Arun Kumar Srivastva; Vijaya Lakshmi Nag; Narendra Krishnani; Anand Kumar Maurya; Tapan N Dhole; Sunil G Babu
Journal:  Indian J Orthop       Date:  2014-01       Impact factor: 1.251

6.  Magnetic Resonance Imaging and GeneXpert: A Rapid and Accurate Diagnostic Tool for the Management of Tuberculosis of the Spine.

Authors:  Ayush Sharma; Harvinder Singh Chhabra; Rajat Mahajan; Tarun Chabra; Sahil Batra
Journal:  Asian Spine J       Date:  2016-10-17

7.  Evaluation of clinico-radiological, bacteriological, serological, molecular and histological diagnosis of osteoarticular tuberculosis.

Authors:  Anil K Jain; Santosh Kumar Jena; M P Singh; I K Dhammi; V G Ramachadran; Geeta Dev
Journal:  Indian J Orthop       Date:  2008-04       Impact factor: 1.251

8.  Mycobacterium tuberculosis monoarthritis in a child.

Authors:  Derek Rajakumar; Alan M Rosenberg
Journal:  Pediatr Rheumatol Online J       Date:  2008-09-18       Impact factor: 3.054

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.